RecruitingNCT04943588

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Queen Mary University of London
Principal Investigator
Graham R Foster, MBBS
Queen Mary University
Intervention
HCV RNA (PCR)(diagnostic_test)
Enrollment
25000 target
Eligibility
18-100 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

Aga Khan University · Dow University of Health Sciences · University of Oxford · University of Bristol

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04943588 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials